Welcome to our dedicated page for Owlet SEC filings (Ticker: OWLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Owlet, Inc. filings document regulatory disclosures for a public pediatric health technology company whose Class A common stock trades on the New York Stock Exchange under OWLT. Recent Form 8-K reports cover operating results, business updates, executive leadership changes, annual meeting matters and stockholder approval of amendments to the company's equity incentive plan.
The filing record also includes disclosures tied to capital structure and financing activity, including preliminary financial information related to an offering and borrowings under an asset-based revolving credit facility. Other material-event filings document shareholder derivative litigation settlement notices, exchange-listed securities, governance matters and exhibits furnished with earnings releases.
Owlet, Inc. reports that a federal court has preliminarily approved a settlement of a derivative lawsuit related to past statements about its Smart Sock product. The case, brought on behalf of the company in the Central District of California, involved certain current and former directors and a stockholder.
Under the settlement terms, Owlet has agreed to implement and maintain specified changes to certain corporate governance practices and the claims related to the allegations in the derivative action will be released, with no admission of wrongdoing. Owlet will be responsible for paying attorney’s fees in an amount that has not yet been determined. The settlement remains subject to court approval, after which all claims in the derivative action would be dismissed with prejudice.
Owlet, Inc. is asking stockholders to vote on six proposals at its virtual 2025 Annual Meeting, including the election of three Class I directors (Zane Burke, John Kim and Melissa Gonzales) and a +375,000 share amendment to its 2021 Equity Incentive Plan to increase shares available for grants. The Board unanimously recommends FOR the plan amendment, ratification of PwC as auditor, approval of an amendment to the Certificate of Incorporation to exculpate officers to the extent permitted by Delaware law, and the adjournment proposal if additional solicitations are needed.
The proxy also seeks stockholder approval under NYSE rules for an exchange of warrants for 5,426,429 shares of Common Stock (Proposal 5); a Special Committee negotiated valuation terms using a 60-day VWAP reference and obtained a 180-day lockup. Holders representing approximately 44% of voting power have agreed to vote in favor of Proposal 5. The proxy discloses governance, compensation and related-party matters, director biographies, and successor CEO transition plans (Kurt Workman to Executive Chairman; Jonathan Harris to become CEO effective October 1, 2025). Closing NYSE price cited: $7.76 on August 15, 2025.
Owlet, Inc. asks stockholders to vote on six proposals at its virtual 2025 Annual Meeting, including election of three Class I directors, an equity plan amendment adding 375,000 shares to the 2021 Incentive Plan, ratification of PwC as independent auditor, an amendment to the certificate of incorporation to permit officer exculpation under Delaware law, approval for issuance of common stock upon exchange of outstanding warrants, and a possible adjournment to solicit additional proxies.
The Proxy explains voting methods (internet, phone, mail, virtual meeting), proxy deadlines (voting facilities close at 11:59 p.m. ET on October 7, 2025), quorum rules, broker non-vote effects, director qualifications and biographies for nominees Burke, Kim and Gonzales, recent and proposed capital-structure actions including a proposed exchange of Series A and B warrants for 5,426,429 shares if stockholders approve NYSE-required issuance, related-party interests (several holders and directors would receive Exchange Shares), and director/compensation governance practices.
Owlet entered a privately negotiated Exchange Agreement to swap outstanding warrants for newly issued common stock and related governance commitments. Holders agreed to exchange Series A warrants relating to 7,215,737 shares and Series B warrants relating to 1,799,021 shares for an aggregate of 5,426,429 newly issued shares of Class A common stock. The Exchanges are subject to stockholder approval under NYSE rules and other customary closing conditions and may be terminated if not closed by November 5, 2025. Major participating holders include an entity affiliated with Eclipse (holding ~29% of voting power in Company Voting Securities), Trilogy (~6.7%), the CEO, and a board member, each to receive specified exchanged shares. The Exchanged Shares will be locked up for 180 days post-closing and the company will seek to register resale under the Securities Act, filing a shelf or prospectus supplement within 30 days after closing. The Company used a Black-Scholes model with the 60-day VWAP and realized volatility to value the warrants for the Exchange.
Owlet, Inc. delivered revenue of $26.1 million for the quarter and $47.2 million for the six months, both increases versus the prior-year periods, and reported improved gross profit margins. Operating losses narrowed on a six-month basis to $(4.6) million from $(8.0) million a year earlier, reflecting higher sales and controlled operating expenses.
Despite revenue growth and a cash balance of $21.8 million, the company recorded a large non-cash $34.8 million common stock warrant liability adjustment in the quarter that drove a GAAP net loss of $(37.6) million for the three months. Total liabilities rose to $108.0 million and stockholders’ deficit widened to $(59.2) million. Management discloses substantial doubt about the company’s ability to continue as a going concern and relies on existing credit facilities (an ABL line and a term loan) and potential financings. Customer concentration is high: one customer accounted for 64% of quarter revenue and 68% of receivables.